Revision as of 04:40, 18 January 2006 editBldavids (talk | contribs)133 edits →neuropsychiatric aspects of parkinson's disease← Previous edit | Latest revision as of 02:02, 26 December 2024 edit undoChristieBot (talk | contribs)Bots, Template editors100,373 editsm Transcluding GA review | ||
Line 1: | Line 1: | ||
{{GA nominee|18:01, 23 December 2024 (UTC)|nominator= ~ ]]|page=3|subtopic=Biology and medicine|status=onreview|note=|shortdesc=Progressive neurodegenerative disease}} | |||
== Awakenings == | |||
{{Talk header}} | |||
''Awakenings'' deals with Parkinson's? I thought it was ]. - ] | |||
{{Article history | |||
|action1=FAC | |||
|action1date=21:24, 28 April 2007 | |||
|action1link=Misplaced Pages:Featured article candidates/Parkinson's disease/archive1 | |||
|action1result=not promoted | |||
|action1oldid=126207719 | |||
|action2=GAN | |||
The patients in ''Awakenings'' were suffering from ''post-encephalitic Parkinsonism''. The encephalitis had occurred 50 years earlier and the infection was over. However it had left damage, causing their Parkinsonism. ] 06:06 Nov 2, 2002 (UTC) | |||
|action2date=20:29, 17 August 2009 | |||
|action2link=Talk:Parkinson's disease/GA1 | |||
|action2result=not listed | |||
|action2oldid=308474814 | |||
|action3=GAN | |||
|action3date=17:54, 15 January 2011 | |||
|action3link=Talk:Parkinson's disease/GA2 | |||
|action3result=listed | |||
|action3oldid=408051407 | |||
|action4=FAC | |||
== Amphetamines == | |||
|action4date=21:28, 5 March 2011 | |||
I think it is more than worthwhile to mention amphetamines as a possible cause. | |||
|action4link=Misplaced Pages:Featured article candidates/Parkinson's disease/archive2 | |||
(Minor comment reg. your last statement: the epidemic was in 1919-20 and the movie appears to play in the early fifties...which fits to the CV of Oliver Saks :-) | |||
|action4result=promoted | |||
|action4oldid=417226916 | |||
|action5 = FAR | |||
I'm sorry I edited the page. I was trying to prove to someone it doesn't actually edit it in real-time. Boy was I wrong. I did fix it though. Sorry again. | |||
|action5date = 2020-10-17 | |||
|action5link = Misplaced Pages:Featured article review/Parkinson's disease/archive1 | |||
|action5result = demoted | |||
|action5oldid = 983527781 | |||
|currentstatus=FFA | |||
|topic=medicine | |||
|maindate=April 11, 2011 | |||
}} | |||
{{WikiProject banner shell|class=B|collapsed=yes|vital=yes|1= | |||
{{WikiProject Medicine|importance=Top|neurology=yes|neurology-imp=Top|psychiatry=yes|psychiatry-imp=high}} | |||
{{WikiProject Psychology|importance=Mid}} | |||
{{WikiProject Disability}} | |||
{{WikiProject Neuroscience |importance=High}} | |||
}} | |||
{{Reliable sources for medical articles}} | |||
{{banner holder|collapsed=yes| | |||
{{Copied | |||
|from1 = Parkinson's disease | |||
|to1 = Signs and symptoms of Parkinson's disease | |||
|diff1 = http://en.wikipedia.org/search/?title=Talk:Signs_and_symptoms_of_parkinson%27s_disease&oldid=347282322 | |||
|from2 = Parkinson's disease | |||
it's worth noting that ritalin is quite useful for the ADD like deficits in attention in PD.] 05:46, 10 January 2006 (UTC) | |||
|to2 = Parkinson's disease clinical research | |||
|diff2 = http://en.wikipedia.org/search/?title=Parkinson%27s_disease_clinical_research&action=historysubmit&diff=380456247&oldid=380447581 | |||
|from3 = Parkinson's disease | |||
== Ozzy? == | |||
|to3 = Treatments of Parkinson's Disease | |||
|from4 = Parkinson's disease | |||
Does Ozzy Ozbourne really have Parkinsons Disease? I know he has Parkinsonian symptoms, but I thought it was due to drug-induced damage to the dopaminergic system rather than actual PD. - ] 22:24, Nov 18, 2004 (UTC | |||
|to4 = Braak staging | |||
|diff4 = https://secure.wikimedia.org/wikipedia/en/search/?title=Braak_staging&oldid=409531043 | |||
|from5 = Parkinson's disease | |||
|to5 = Lee Silverman voice treatment | |||
|diff5 = https://secure.wikimedia.org/wikipedia/en/search/?title=Lee_Silverman_voice_treatment&oldid=409532533 | |||
|from6 = Parkinson's disease | |||
The first name seems to be the more popular and proper one, being referenced more often in recent literature and on Google. ] 11:10, 23 Nov 2004 (UTC) | |||
|to6 = History of Parkinson's disease | |||
|diff6 = http://en.wikipedia.org/search/?title=Parkinson%27s_disease&oldid=416383471 | |||
}} | |||
{{Backwards copy | |||
| title = Parkinson's Disease and other Movement Disorders: A Review | |||
| year = 2017 | |||
| author = Fymat, Alain L: International Institute of Medicine and Science | |||
| display-authors = | |||
| url = https://scientiaricerca.com/srcons/SRCONS-02-00047.php | |||
| org = Scientia Ricerca | |||
| monthday = December 23, | |||
| id = 792704852 | |||
| comments = See ] | |||
}} | |||
}} | |||
{{Archive basics | |||
|archive= Talk:Parkinson's disease/Archive %(counter)d | |||
|counter = 7 | |||
|headerlevel = 2 | |||
|maxarchivesize = 200K | |||
|archiveheader = {{Aan}} | |||
}} | |||
{{User:ClueBot III/ArchiveThis | |||
| age=2160|<!--90 days--> | |||
| archiveprefix=Talk:Parkinson's disease/Archive | |||
| archivenow={{User:ClueBot III/ArchiveNow}} | |||
| maxarchsize=150000 | |||
| header={{automatic archive navigator}} | |||
| minkeepthreads=4 | |||
| numberstart=7 | |||
| format= %%i | |||
}} | |||
==Wiki Education assignment: Biology I from cells to organisms== | |||
== "inclinations towards Catholicism" == | |||
{{dashboard.wikiedu.org assignment | course = Misplaced Pages:Wiki_Ed/First_Nations_University/Biology_I_from_cells_to_organisms_(fall) | assignments = ] | start_date = 2024-09-05 | end_date = 2024-12-05 }} | |||
<span class="wikied-assignment" style="font-size:85%;">— Assignment last updated by ] (]) 05:54, 24 September 2024 (UTC)</span> | |||
Is this a bogus edit? | |||
:It's a jibe at John Paul II. ] | ] 00:49, 18 August 2005 (UTC) | |||
==RfC: Should the four lead images be replaced?== | |||
== removed Katharine Hepburn == | |||
<!-- ] 03:01, 18 January 2025 (UTC) -->{{User:ClueBot III/DoNotArchiveUntil|1737169273}} | |||
{{closed rfc top|result=There is a resounding consensus against having this Lewy body as the lead image, so I'll close this per ]. ~ ]] 21:29, 15 December 2024 (UTC)}} | |||
Katharine Hepburn did not have Parkinson's Disease. She had a condition called Essential tremor. | |||
Should the four images currently used in the infobox be replaced with ] of a ] below? ~ ]] 02:03, 14 December 2024 (UTC) | |||
== Micrographia == | |||
] (stained brown), an abnormal ] found in neurons, a hallmark of Parkinson's disease]] | |||
One of the symptoms mentioned is "micrographia (small handwriting)" — is this accurate? Is small handwriting symptomatic of disease? Either way, the link currently goes to an article about a popular science book, which I don't think was the author's intention. -- ] 20:04, 17 August 2005 (UTC) | |||
===Past Discussions=== | |||
:Well, micrographia alone is not particularly indicative of PD. In the context of other symptoms, though, it is an informative symptom. ] | ] 00:48, 18 August 2005 (UTC) | |||
, , , , , , ~ ]] 02:03, 14 December 2024 (UTC) | |||
=== Discussion === | |||
*'''Support new image''' The current four images are low-quality, inconsistent, and unnecessarily clutter the infobox. More importantly, they fail to represent Parkinson's disease accurately, given its highly variable symptoms, which range from low blood pressure to cognitive decline. It's not even very clear what symptoms the current lead images are trying to illustrate, like the circled foot. These images violate ] as they are not genuinely representative. In contrast, a Lewy body—widely recognized as the hallmark biological feature of Parkinson's disease—provides a more accurate and universal depiction. Trying to accurately depict patients afflicted with a disease in the lead image is almost impossible and is not the standard on Misplaced Pages: see ], ], ], or other neurodegenerative diseases like ], the FA ], ], ], ], or ]. ~ ]] 02:03, 14 December 2024 (UTC) | |||
*:If anyone needs a direct comparison, these are the lead images on related articles: | |||
<gallery mode="packed"> | |||
File:MS Demyelinisation CD68 10xv2.jpg|] | |||
File:Lewy body in the substantia nigra from a person with Parkinson's disease.jpg|] | |||
File:Neuron with mHtt inclusion.jpg|] | |||
File:MSA aSynuclein.jpg|] | |||
File:BrainAtrophy(exvacuo).png|] | |||
File:Leigh Trichrom.jpg|] | |||
</gallery> | |||
*'''No''' {{sbb}} I don't find microscopic images of damaged tissue very informative to understanding the effect of a disease. The current image has been in the article for about one year, and of the "Gowers' illustration" was in the article as early as . In 2011, it was even a featured article with the "Gowers' illustration". Based on the discussions I included above, the Gowler's illustration seems historically significant--so I prefer seeing it included high up in the article as it is now. There seems to be a long-running consensus to keep an image such as the current one. About a year ago was floated and apparently rejected, which might be an acceptable alternative to the current one. --] (]) 04:28, 14 December 2024 (UTC) | |||
*'''No'''. I don't think the proposed picture of a Lewy body helps the reader to understand anything at all about Parkinson's. --] (]) 11:21, 14 December 2024 (UTC) | |||
*'''No''': per above. --<span style="font-family:Times New Roman;font-size:100%;color:#00008B;background-color:transparent;;CSS">]]</span> 16:05, 15 December 2024 (UTC) | |||
*'''No'''. The proposed Lewy body image assumes the general user would understand or recognize the cellular effect, which is unlikely; see ] and ] #6,7. The disease symptoms image ] is a good choice for general users to visually grasp the article. ] (]) 19:31, 15 December 2024 (UTC) | |||
{{closed rfc bottom}} | |||
== Prevention section == | |||
The statement is accurate; it's a classic symptom. So, its presence is definitely informative but not diagnostic. sensitive but not specific. ] 05:48, 10 January 2006 (UTC) | |||
The subhead is misnamed - there is no 'prevention', only potential reduction of risk. All the sources used in this section are research-in-progress. The section should be retitled 'Research on risk reduction' and moved to below the 'Prognosis' section. ] (]) 19:42, 15 December 2024 (UTC) | |||
== Exercise neuroprotective == | |||
:The "Prevention" subsection has been around for quite some time, and is the standard on related articles like ], and is suggested per ]. I think that this objection might be rooted in a misunderstanding of the meaning of "prevention" in a medical context. It quite literally means "potential reduction of risk" (per the NIH: ""). Also, "Research on risk reduction" is a somewhat ungainly title, and don't essentially all of these subsections result from research? Should they all be titled "Research on X"? It seems redundant. ~ ]] 21:26, 15 December 2024 (UTC) | |||
::The word prevention may mislead general non-science users to conclude there are ''certain'' lifestyle practices for avoiding PD, ]. Moving this section into the 'Clinical research' topics seems the best place for it, but it should be significantly trimmed. | |||
::The phrases "may have a protective effect", "hypothesized to be neuroprotective" or "proposed to be neuroprotective" are non-neutral (as they may not), are based on primary research, and are ]. That is why I removed ] (]) 22:26, 15 December 2024 (UTC) | |||
:::Yes, some of that material was cited to primary research papers and you rightly removed them. However, the only sources I've used in that subsection are secondary review articles. Also, the subsection immediately and explicitly states "no disease-modifying therapies exist that reverse or slow neurodegeneration" at the very beginning, so I don't think anyone is being misled. | |||
:::Regardless, although I see "Prevention" as a fine subtitle, do you think maybe retitling it as "Neuroprotection" or "Potential neuroprotection" would be a sufficient compromise? I also would not be opposed to splitting "Risk factors" from the "Causes" sections and then having a "Risk factors" section (as we used to) with "Positive risk factors" and "Negative risk factors" subtitles. ~ ]] 22:57, 15 December 2024 (UTC) | |||
::::Better to use the positive and negative risk factors for subheads. Also, is not ]-indexed, so its content should be removed as unreliable. The ''Frontiers'' journals trigger a dubious source alert - would be good to find better reviews or remove them. ] (]) 00:13, 16 December 2024 (UTC) | |||
:::::Sounds good, I'll integrate the Prevention section and take a look at those sources tomorrow. Cheers, ~ ]] 04:34, 16 December 2024 (UTC) | |||
::::::There isn't really a concept of "positive risk factor" or "negative risk factor" so please don't create these as separate headers. You could talk about "protective risk factors" which is sometimes done. But probably best to just have a "risk factor" section. Smoking is a risk factor for lung cancer. Quit and it is protective. Start and it is the opposite. Same for most other risk factors - depends on whether the dose is increasing or decreasing. ] (]) 05:14, 20 December 2024 (UTC) | |||
:::::Frontiers review articles should be OK. See ]. But if there is a higher profile or more recent reference for the same thing, may be better to replace it. If it is an extreme or implausible claim, then be careful of any single source. ] (]) 05:17, 20 December 2024 (UTC) | |||
:The concept of "prevention" includes interventions that are not 100% guaranteed to stop a disease. So a section on lifestyle interventions (such as exercise) that prevent (or stave off) PD is reasonable. All of medicine is in a process of continuous research, so it may not be necessary to overly emphasize that interventions (such as exercise) that are backed by a lot of research belong in a separate "researchy stuff" section. This article is in the scope of ], so it makes sense to follow WikiProject Medicine guidelines. I am not quite sure what a "non-science" user is, but if there is some writing that is hard to understand, we can work on making it more understandable, including links to epistemological concepts like ] (which needs some work) and ]. ] (]) 05:26, 20 December 2024 (UTC) | |||
== Broken references == | |||
I am dubious about the alleged "neuroprotective effect" of exercise. I'd like to see a reference please. --] 23:23, 23 September 2005 (UTC) | |||
@] I've fixed a bunch of the shortened footnotes – you might like to double-check the edits in , but there were a handful I couldn't work out (ref numbers are in of the article): | |||
* #35 Weintraub & Mamikonyan 2019, p. 661 – I found but the page numbers don't match. Perhaps it's a typo for the paper cited in the previous reference? | |||
See: “Parkinson's Disease” an on-line summary @http://www.bcm.edu/neurol/jankovic/educ_pd.htm, by Joseph Jankovic, M.D., an internationally recognized expert on Parkinson disease, and the medical director of the Udall Parkinson Disease Research and Treatment Center in Houston (Note: “Udall Center” is a federal designation denoting excellence in PD treatment and research): | |||
* #42 Palma & Kaufmann 2020, pp. 1465–1466 – I corrected the other Palma & Kaufmann refs to 2018, but here the page numbers don't match | |||
“Recent animal research has provided strong evidence that exercise can increase brain levels of neurotrophic factors, increase resistance to brain insult or injury, and improve learning and mental as well as motor performance.” There are a number of animal studies I could cite here, but Dr. Jankovic is a highly credible source and that quote saves me a lot of time.] 05:50, 10 January 2006 (UTC) | |||
* #65 Tanner & Ostrem 2024 – no idea about this one | |||
* #230 Corcoran, Muiño & Kluger 2021, p. 1 – ditto. | |||
:Here's a good place to start: PMID 15214505. (Then click on "Related Articles" and you'll see many studies on the topic.) --] 18:08, 3 January 2006 (UTC) | |||
You might like to consider installing ], which highlights problems with {{tl|sfn}}s for you in lurid pink – I find it invaluable. Thanks for your work on the article, and thanks in advance for fixing the references above. Good luck at GAN! Best, ] (]) 21:00, 24 December 2024 (UTC) | |||
{{Talk:Parkinson's disease/GA3}} | |||
: see also: | |||
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15790541&query_hl=25&itool=pubmed_docsum | |||
== Terminology depends on which side of the Atlantic you are on == | |||
Parkinson disease is used in American scientific literature. There has bee a move away from the apostrophe (e.g. Alzheimer disease vs. Alzheimer's disease). The British and the rest of the world use "Parkinson's disease" (preferred term). | |||
] 00:40, 20 October 2005 (UTC)M K Lee | |||
== neuropsychiatric aspects of parkinson's disease== | |||
Depression, anxiety, and executive dysfunction have been estimated to account for up to 70 percent of the disability associated with Parkinson disease. Dementia and psychosis may ultimately effect more than a third of all Parkinson patients. There is a movement among researchers and patients to weaken the emphasis on "movement disorder" and strengthen the emphasis on "neuropsychiatric disease".] 06:35, 16 January 2006 (UTC) | |||
:If you have documentary support for this shift in paradigm it would make a very important point in the article. ] | ] 12:17, 16 January 2006 (UTC) | |||
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15043801&query_hl=3&itool=pubmed_docsum | |||
see also: | |||
Curr Psychiatry Rep. 2003 May;5(1):68-76. Related Articles, Links | |||
Neuropsychiatric aspects of Parkinson's disease: recent advances. | |||
Marsh L, Berk A. Division of Psychiatric Neuroimaging, Geriatric and Neuropsychiatry Programs, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, 600 North Wolfe Street, Phipps 300-C, Baltimore, MD 21287, USA. lmarsh@jhmi.edu | |||
Psychiatric disturbances are a common feature of Parkinson's disease (PD), which is a degenerative disorder defined by its characteristic movement abnormalities. Its management is optimal when PD is viewed as a neuropsychiatric disorder, because this encourages consideration of the motor deficits along with its psychiatric and cognitive aspects. This review addresses the diagnosis and treatment of the most common psychiatric disorders in PD, and provides an update of related clinical research, including studies on neurosurgical treatments. | |||
== Symptoms that cross over the physical into the cognitive and affective realms== | |||
The lists as constituted are poor vehicles for certain symptom sets: for example, speech-language problems. In PD, there are defects in articulation and breath support and voicing, but there are also problems with comprehension of complex syntax, with word finding, and with both expression and reception of prosody. Likewise vision and visual processing: the defects in vision are quite complex, seemingly a function of the combined effect of impaired attending, impaired gating of response, and slowed reaction time. The physical and cognitive and affective components of the disease are all snarled together, because the job of the pre-frontal cortex is precisely the integration of these kinds of inputs and outputs. The dysfunction observed in the prefrontal cortex when deprived of dopamine is subtle but radical: disconnects between physical stimulae and perception, between intention and action, between feelings and responses. At some point, these lists will not serve. ] 23:18, 17 January 2006 (UTC) |
Latest revision as of 02:02, 26 December 2024
Parkinson's disease is currently a Biology and medicine good article nominee. Nominated by ~ HAL333 at 18:01, 23 December 2024 (UTC) An editor has indicated a willingness to review the article in accordance with the good article criteria and will decide whether or not to list it as a good article. Comments are welcome from any editor who has not nominated or contributed significantly to this article. This review will be closed by the first reviewer. To add comments to this review, click discuss review and edit the page. Short description: Progressive neurodegenerative disease |
This is the talk page for discussing improvements to the Parkinson's disease article. This is not a forum for general discussion of the article's subject. |
|
Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL |
Archives: Index, 1, 2, 3, 4, 5, 6, 7, 8Auto-archiving period: 3 months |
Parkinson's disease is a former featured article. Please see the links under Article milestones below for its original nomination page (for older articles, check the nomination archive) and why it was removed. | |||||||||||||||||||||||||
This article appeared on Misplaced Pages's Main Page as Today's featured article on April 11, 2011. | |||||||||||||||||||||||||
|
This level-4 vital article is rated B-class on Misplaced Pages's content assessment scale. It is of interest to multiple WikiProjects. | ||||||||||||||||||||||||||||||||||||||||||||
|
Ideal sources for Misplaced Pages's health content are defined in the guideline Misplaced Pages:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Parkinson's disease.
|
Other talk page banners | |||||||
|
Wiki Education assignment: Biology I from cells to organisms
This article was the subject of a Wiki Education Foundation-supported course assignment, between 5 September 2024 and 5 December 2024. Further details are available on the course page. Student editor(s): TTK043 (article contribs).
— Assignment last updated by TTK043 (talk) 05:54, 24 September 2024 (UTC)
RfC: Should the four lead images be replaced?
- The following discussion is an archived record of a request for comment. Please do not modify it. No further edits should be made to this discussion. A summary of the conclusions reached follows.
Should the four images currently used in the infobox be replaced with this one of a Lewy body below? ~ HAL333 02:03, 14 December 2024 (UTC)
Past Discussions
2023, 2022, 2013, 3-25-2011, 3-8-2011, 2008, 2006 ~ HAL333 02:03, 14 December 2024 (UTC)
Discussion
- Support new image The current four images are low-quality, inconsistent, and unnecessarily clutter the infobox. More importantly, they fail to represent Parkinson's disease accurately, given its highly variable symptoms, which range from low blood pressure to cognitive decline. It's not even very clear what symptoms the current lead images are trying to illustrate, like the circled foot. These images violate Misplaced Pages:Manual of Style/Lead section as they are not genuinely representative. In contrast, a Lewy body—widely recognized as the hallmark biological feature of Parkinson's disease—provides a more accurate and universal depiction. Trying to accurately depict patients afflicted with a disease in the lead image is almost impossible and is not the standard on Misplaced Pages: see Cancer, Tuberculosis, Syphilis, or other neurodegenerative diseases like Huntington's disease, the FA Dementia with Lewy bodies, Multiple sclerosis, Alzheimer's disease, ALS, or Creutzfeldt–Jakob disease. ~ HAL333 02:03, 14 December 2024 (UTC)
- If anyone needs a direct comparison, these are the lead images on related articles:
- Multiple sclerosis
- Dementia with Lewy bodies
- Huntington's disease
- Multiple system atrophy
- Vascular dementia
- Leigh syndrome
- No (Summoned by bot) I don't find microscopic images of damaged tissue very informative to understanding the effect of a disease. The current image has been in the article for about one year, and this simpler image of the "Gowers' illustration" was in the article as early as 6-1-2019. In 2011, it was even a featured article with the "Gowers' illustration". Based on the discussions I included above, the Gowler's illustration seems historically significant--so I prefer seeing it included high up in the article as it is now. There seems to be a long-running consensus to keep an image such as the current one. About a year ago this image was floated and apparently rejected, which might be an acceptable alternative to the current one. --David Tornheim (talk) 04:28, 14 December 2024 (UTC)
- No. I don't think the proposed picture of a Lewy body helps the reader to understand anything at all about Parkinson's. --Alarics (talk) 11:21, 14 December 2024 (UTC)
- No: per above. --ZZ'S 16:05, 15 December 2024 (UTC)
- No. The proposed Lewy body image assumes the general user would understand or recognize the cellular effect, which is unlikely; see WP:WFTWA and WP:NOTTEXTBOOK #6,7. The disease symptoms image is a good choice for general users to visually grasp the article. Zefr (talk) 19:31, 15 December 2024 (UTC)
Prevention section
The subhead is misnamed - there is no 'prevention', only potential reduction of risk. All the sources used in this section are research-in-progress. The section should be retitled 'Research on risk reduction' and moved to below the 'Prognosis' section. Zefr (talk) 19:42, 15 December 2024 (UTC)
- The "Prevention" subsection has been around for quite some time, and is the standard on related articles like Alzheimer's disease, and is suggested per WP:MEDMOS. I think that this objection might be rooted in a misunderstanding of the meaning of "prevention" in a medical context. It quite literally means "potential reduction of risk" (per the NIH: "Prevention = In medicine, action taken to decrease the chance of getting a disease or condition"). Also, "Research on risk reduction" is a somewhat ungainly title, and don't essentially all of these subsections result from research? Should they all be titled "Research on X"? It seems redundant. ~ HAL333 21:26, 15 December 2024 (UTC)
- The word prevention may mislead general non-science users to conclude there are certain lifestyle practices for avoiding PD, WP:WFTWA. Moving this section into the 'Clinical research' topics seems the best place for it, but it should be significantly trimmed.
- The phrases "may have a protective effect", "hypothesized to be neuroprotective" or "proposed to be neuroprotective" are non-neutral (as they may not), are based on primary research, and are MOS:WEASEL. That is why I removed this. Zefr (talk) 22:26, 15 December 2024 (UTC)
- Yes, some of that material was cited to primary research papers and you rightly removed them. However, the only sources I've used in that subsection are secondary review articles. Also, the subsection immediately and explicitly states "no disease-modifying therapies exist that reverse or slow neurodegeneration" at the very beginning, so I don't think anyone is being misled.
- Regardless, although I see "Prevention" as a fine subtitle, do you think maybe retitling it as "Neuroprotection" or "Potential neuroprotection" would be a sufficient compromise? I also would not be opposed to splitting "Risk factors" from the "Causes" sections and then having a "Risk factors" section (as we used to) with "Positive risk factors" and "Negative risk factors" subtitles. ~ HAL333 22:57, 15 December 2024 (UTC)
- Better to use the positive and negative risk factors for subheads. Also, this source is not MEDLINE-indexed, so its content should be removed as unreliable. The Frontiers journals trigger a dubious source alert - would be good to find better reviews or remove them. Zefr (talk) 00:13, 16 December 2024 (UTC)
- Sounds good, I'll integrate the Prevention section and take a look at those sources tomorrow. Cheers, ~ HAL333 04:34, 16 December 2024 (UTC)
- There isn't really a concept of "positive risk factor" or "negative risk factor" so please don't create these as separate headers. You could talk about "protective risk factors" which is sometimes done. But probably best to just have a "risk factor" section. Smoking is a risk factor for lung cancer. Quit and it is protective. Start and it is the opposite. Same for most other risk factors - depends on whether the dose is increasing or decreasing. Jaredroach (talk) 05:14, 20 December 2024 (UTC)
- Frontiers review articles should be OK. See WP:MEDRS. But if there is a higher profile or more recent reference for the same thing, may be better to replace it. If it is an extreme or implausible claim, then be careful of any single source. Jaredroach (talk) 05:17, 20 December 2024 (UTC)
- Sounds good, I'll integrate the Prevention section and take a look at those sources tomorrow. Cheers, ~ HAL333 04:34, 16 December 2024 (UTC)
- Better to use the positive and negative risk factors for subheads. Also, this source is not MEDLINE-indexed, so its content should be removed as unreliable. The Frontiers journals trigger a dubious source alert - would be good to find better reviews or remove them. Zefr (talk) 00:13, 16 December 2024 (UTC)
- The concept of "prevention" includes interventions that are not 100% guaranteed to stop a disease. So a section on lifestyle interventions (such as exercise) that prevent (or stave off) PD is reasonable. All of medicine is in a process of continuous research, so it may not be necessary to overly emphasize that interventions (such as exercise) that are backed by a lot of research belong in a separate "researchy stuff" section. This article is in the scope of WP:MED, so it makes sense to follow WikiProject Medicine guidelines. I am not quite sure what a "non-science" user is, but if there is some writing that is hard to understand, we can work on making it more understandable, including links to epistemological concepts like risk factor (which needs some work) and causality. Jaredroach (talk) 05:26, 20 December 2024 (UTC)
Broken references
@HAL333 I've fixed a bunch of the shortened footnotes – you might like to double-check the edits in this combined diff, but there were a handful I couldn't work out (ref numbers are in this version of the article):
- #35 Weintraub & Mamikonyan 2019, p. 661 – I found this source but the page numbers don't match. Perhaps it's a typo for the paper cited in the previous reference?
- #42 Palma & Kaufmann 2020, pp. 1465–1466 – I corrected the other Palma & Kaufmann refs to 2018, but here the page numbers don't match
- #65 Tanner & Ostrem 2024 – no idea about this one
- #230 Corcoran, Muiño & Kluger 2021, p. 1 – ditto.
You might like to consider installing this script, which highlights problems with {{sfn}}s for you in lurid pink – I find it invaluable. Thanks for your work on the article, and thanks in advance for fixing the references above. Good luck at GAN! Best, Wham2001 (talk) 21:00, 24 December 2024 (UTC)
GA Review
GA toolbox |
---|
Reviewing |
- This review is transcluded from Talk:Parkinson's disease/GA3. The edit link for this section can be used to add comments to the review.
Nominator: HAL333 (talk · contribs) 18:01, 23 December 2024 (UTC)
Reviewer: IntentionallyDense (talk · contribs) 01:52, 26 December 2024 (UTC)
- This is a huge topic so it may take me longer than usual to review, I'll fill out the table as I go and make comments below so it is easier for you to respond. At first glance, there is a few SFN errors that should be fixed. Additionally per WP:MEDDATE we should be using articles published within the last 5 years wherever possible. Because Parkinsons is such a hot topic I would imagine there is enough research to be able to do this. If you plan on taking this to FAC then I'd try to use the 5 year rule, but for the sake of GAN I try to stick to 10 years. Meaning every source published before 2015 (excluding NICE reviews, Cocheran reviews, and history section) should be replaced with more recent sources. IntentionallyDense 01:52, 26 December 2024 (UTC)
Rate | Attribute | Review Comment |
---|---|---|
1. Well-written: | ||
1a. the prose is clear, concise, and understandable to an appropriately broad audience; spelling and grammar are correct. | ||
1b. it complies with the Manual of Style guidelines for lead sections, layout, words to watch, fiction, and list incorporation. | ||
2. Verifiable with no original research, as shown by a source spot-check: | ||
2a. it contains a list of all references (sources of information), presented in accordance with the layout style guideline. | IntentionallyDense 21:14, 26 December 2024 (UTC) | |
2b. reliable sources are cited inline. All content that could reasonably be challenged, except for plot summaries and that which summarizes cited content elsewhere in the article, must be cited no later than the end of the paragraph (or line if the content is not in prose). | ||
2c. it contains no original research. | ||
2d. it contains no copyright violations or plagiarism. | ||
3. Broad in its coverage: | ||
3a. it addresses the main aspects of the topic. | ||
3b. it stays focused on the topic without going into unnecessary detail (see summary style). | ||
4. Neutral: it represents viewpoints fairly and without editorial bias, giving due weight to each. | ||
5. Stable: it does not change significantly from day to day because of an ongoing edit war or content dispute. | IntentionallyDense 21:14, 26 December 2024 (UTC) | |
6. Illustrated, if possible, by media such as images, video, or audio: | ||
6a. media are tagged with their copyright statuses, and valid non-free use rationales are provided for non-free content. | IntentionallyDense 02:24, 26 December 2024 (UTC) | |
6b. media are relevant to the topic, and have suitable captions. | Some minor issues are listed below. IntentionallyDense 02:24, 26 December 2024 (UTC) | |
7. Overall assessment. | On hold until HAL333 can address the issues I have found thusfar. IntentionallyDense 21:14, 26 December 2024 (UTC) |
Images
- For the image under the motor section of symptoms "diminutive handwriting" isn't defined which is an issue cause the wikilink doesn't really help. A quick explanation would be nice. IntentionallyDense 02:24, 26 December 2024 (UTC)
- Under the autonomic section, I don't feel like your image caption of Dysphagia—an autonomic failure—and subsequent complications like aspiration pneumonia (pictured) reduce quality of life. is super helpful here. Could it be changed to something along the lines of
Dysphagia can lead to aspiration pneumonia (pictured)
as the QOL isn't brought up elsewhere in this section so it feels out of place. IntentionallyDense 02:24, 26 December 2024 (UTC) - The caption under the two images in the causes section may read better as
The protein alpha-synuclein aggregates into Lewy bodies and neurites. Structural model of alpha-synuclein (left), photomicrograph of Lewy bodies (right).
to better explain the two images. IntentionallyDense 02:24, 26 December 2024 (UTC) - Under imaging the term "F-DOPA" is used but never explained. Is there a wikilink you could add or could you give a brief explanation on this? IntentionallyDense 02:24, 26 December 2024 (UTC)
- Under levodopa the acronym LCE is used. Could you spell this out in full? IntentionallyDense 02:24, 26 December 2024 (UTC)
- The wording of the caption under the tricycle is a little odd. Could you reword it? IntentionallyDense 02:24, 26 December 2024 (UTC)
- Under cell based therapies the caption says "one such iSPC differentiated" but I assume you mean iPSCs. IntentionallyDense 02:24, 26 December 2024 (UTC)
Sources
- You have quite a few borderline sources included here. I'll link all of the ones I found on a quick look. If you could replace as many of these as possible that would be great. IntentionallyDense 21:14, 26 December 2024 (UTC)
- Not all of these will need to be replaced. Try putting the issn into this website. For example, the journal "International journal of molecular sciences" (used in this pub) is indexed in a lot of databases while some of the other journals here aren't indexed in may databases. IntentionallyDense 02:34, 27 December 2024 (UTC)
- Good article nominees
- Good article nominees on review
- Misplaced Pages former featured articles
- Featured articles that have appeared on the main page
- Featured articles that have appeared on the main page once
- B-Class level-4 vital articles
- Misplaced Pages level-4 vital articles in Biology and health sciences
- B-Class vital articles in Biology and health sciences
- B-Class medicine articles
- Top-importance medicine articles
- B-Class neurology articles
- Top-importance neurology articles
- Neurology task force articles
- B-Class psychiatry articles
- High-importance psychiatry articles
- Psychiatry task force articles
- All WikiProject Medicine pages
- B-Class psychology articles
- Mid-importance psychology articles
- WikiProject Psychology articles
- B-Class Disability articles
- WikiProject Disability articles
- B-Class neuroscience articles
- High-importance neuroscience articles